114 related articles for article (PubMed ID: 25361886)
41. Racial and ethnic differences in risk of second primary cancers among breast cancer survivors.
Calip GS; Law EH; Ko NY
Breast Cancer Res Treat; 2015 Jun; 151(3):687-96. PubMed ID: 26012645
[TBL] [Abstract][Full Text] [Related]
42. Impact of ARTs on oncological outcomes in young breast cancer survivors.
Condorelli M; De Vos M; Lie Fong S; Autin C; Delvigne A; Vanden Meerschaut F; Wyns C; Imbert R; Cheruy C; Bouziotis J; de Azambuja E; Delbaere A; Lambertini M; Demeestere I
Hum Reprod; 2021 Jan; 36(2):381-389. PubMed ID: 33289029
[TBL] [Abstract][Full Text] [Related]
43. Who are the breast cancer survivors in Malaysia?
Ibrahim NI; Dahlui M; Aina EN; Al-Sadat N
Asian Pac J Cancer Prev; 2012; 13(5):2213-8. PubMed ID: 22901196
[TBL] [Abstract][Full Text] [Related]
44. Determinants of newly diagnosed comorbidities among breast cancer survivors.
Obi N; Gornyk D; Heinz J; Vrieling A; Seibold P; Chang-Claude J; Flesch-Janys D
J Cancer Surviv; 2014 Sep; 8(3):384-93. PubMed ID: 24570215
[TBL] [Abstract][Full Text] [Related]
45. Low bone mineral density is associated with breast cancer in postmenopausal women: a case-control study.
Ferreira Poloni P; Vespoli HL; Almeida-Filho BS; Bueloni-Dias F; Nahas-Neto J; Nahas EAP
Climacteric; 2017 Oct; 20(5):491-497. PubMed ID: 28569124
[TBL] [Abstract][Full Text] [Related]
46. Body mass index and mortality among older breast cancer survivors in the Study of Osteoporotic Fractures.
Reeves KW; Faulkner K; Modugno F; Hillier TA; Bauer DC; Ensrud KE; Cauley JA;
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1468-73. PubMed ID: 17627012
[TBL] [Abstract][Full Text] [Related]
47. Obesity is an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients.
Karatas F; Erdem GU; Sahin S; Aytekin A; Yuce D; Sever AR; Babacan T; Ates O; Ozisik Y; Altundag K
Breast; 2017 Apr; 32():237-244. PubMed ID: 27318645
[TBL] [Abstract][Full Text] [Related]
48. Obesity and physical inactivity are related to impaired physical health of breast cancer survivors.
Elme A; Utriainen M; Kellokumpu-Lehtinen P; Palva T; Luoto R; Nikander R; Huovinen R; Kautiainen H; Järvenpää S; Penttinen HM; Vehmanen L; Jääskeläinen AS; Ruohola J; Blomqvist C; Saarto T
Anticancer Res; 2013 Apr; 33(4):1595-602. PubMed ID: 23564803
[TBL] [Abstract][Full Text] [Related]
49. Increased Risk of Breast and Uterine Cancer Among Women With Ovarian Granulosa Cell Tumors.
Nasioudis D; Wilson E; Mastroyannis SA; Sisti G; Haggerty AF; Ko EM; Latif NA
Anticancer Res; 2019 Sep; 39(9):4971-4975. PubMed ID: 31519603
[TBL] [Abstract][Full Text] [Related]
50. Risk of metabolic syndrome in postmenopausal breast cancer survivors.
Buttros Dde A; Nahas EA; Vespoli Hde L; Uemura G; de Almeida Bda R; Nahas-Neto J
Menopause; 2013 Apr; 20(4):448-54. PubMed ID: 23149866
[TBL] [Abstract][Full Text] [Related]
51. Thyroid function in women after multimodal treatment for breast cancer stage II/III: comparison with controls from a population sample.
Reinertsen KV; Cvancarova M; Wist E; Bjøro T; Dahl AA; Danielsen T; Fosså SD
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):764-70. PubMed ID: 19286332
[TBL] [Abstract][Full Text] [Related]
52. Quality of life, body mass index, and physical activity among uterine cancer patients.
Lin LL; Brown JC; Segal S; Schmitz KH
Int J Gynecol Cancer; 2014 Jul; 24(6):1027-32. PubMed ID: 24927246
[TBL] [Abstract][Full Text] [Related]
53. Risk Factors and Outcomes During a First Acute Myocardial Infarction in Breast Cancer Survivors Compared with Females Without Breast Cancer.
Yandrapalli S; Malik AH; Pemmasani G; Gupta K; Harikrishnan P; Nabors C; Aronow WS; Cooper HA; Panza JA; Frishman WH; Jain D
Am J Med; 2020 Apr; 133(4):444-451. PubMed ID: 31715170
[TBL] [Abstract][Full Text] [Related]
54. Prognostic impact of the history of breast cancer and of hormone therapy in uterine carcinosarcoma.
Uehara T; Onda T; Togami S; Amano T; Tanikawa M; Sawada M; Ikeda S; Kato T; Kasamatsu T
Int J Gynecol Cancer; 2012 Feb; 22(2):280-5. PubMed ID: 22228427
[TBL] [Abstract][Full Text] [Related]
55. Relationship between breast cancer and thyroid disease: relevance of autoimmune thyroid disorders in breast malignancy.
Giani C; Fierabracci P; Bonacci R; Gigliotti A; Campani D; De Negri F; Cecchetti D; Martino E; Pinchera A
J Clin Endocrinol Metab; 1996 Mar; 81(3):990-4. PubMed ID: 8772562
[TBL] [Abstract][Full Text] [Related]
56. The use of preventive health services among elderly uterine cancer survivors.
McBean AM; Yu X; Virnig BA
Am J Obstet Gynecol; 2008 Jan; 198(1):86.e1-8. PubMed ID: 18166316
[TBL] [Abstract][Full Text] [Related]
57. Hepatosteatosis may predict late recurrence of breast cancer: A single-center observational study.
Kus T; Cinkir HY; Aktas G; Abali H
Curr Probl Cancer; 2019 Dec; 43(6):100461. PubMed ID: 30686567
[TBL] [Abstract][Full Text] [Related]
58. Breast cancer in Hodgkin's disease and non-Hodgkin's lymphoma survivors.
Sanna G; Lorizzo K; Rotmensz N; Bagnardi V; Cinieri S; Colleoni M; Nolè F; Goldhirsch A
Ann Oncol; 2007 Feb; 18(2):288-92. PubMed ID: 17088328
[TBL] [Abstract][Full Text] [Related]
59. Association of the Implant Surface Texture Used in Reconstruction With Breast Cancer Recurrence.
Lee KT; Kim S; Jeon BJ; Pyon JK; Mun GH; Ryu JM; Lee SK; Yu J; Kim SW; Lee JE; Nam SJ; Bang SI
JAMA Surg; 2020 Dec; 155(12):1132-1140. PubMed ID: 33026424
[TBL] [Abstract][Full Text] [Related]
60. A comparison of cardiovascular and pulmonary morbidities and risk factors in breast cancer survivors compared to an age-matched female control group in the Lifelines prospective population cohort.
Spoor DS; van den Bogaard VAB; Sijtsema NM; Van der Meer P; de Bock GH; Langendijk JA; Maduro JH; Crijns APG
Breast; 2023 Aug; 70():49-55. PubMed ID: 37331094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
